< Back to situations

[ORGANIZATION]

Pharming Group

Featured in 1 tracked story · first seen

Situations

[ACTIVE] [HEALTH] [JP] [US]

Joenja pediatric expansion for APDS

2 clusters · 4 sources · last updated

Latest: Pharming receives FDA approval for Joenja in children with APDS

The pharmaceutical company Pharming has expanded the availability of Joenja (leniolisib) for pediatric patients with activated PI3K delta syndrome (APDS) in different global markets. In August 2026, Japan became the fir